An online supplier of antibody products for Life Sciences research organisations around the world, Abcam is enabling scientists to identify more effective solutions to healthcare problems.
Revenue increased by 25.2 per cent to £71.1m last year. Pre-tax profits were up by 58.4 to £25.8m. Abcam’s product range grew by 20.2 per cent to 63,010 antibodies and related products. The company has also grown its own presence globally, expanding its space significantly at Cambridge Science Park and opening new offices in Hong Kong and San Francisco.
|< Prev||Next >|